Patients with AD demonstrate elevated systemic autoantibodies and an increased population of antibody-secreting B cells in peripheral blood.21 Matteo et al. documented that individuals with moderate-to-severe AD report a decrease in peripheral CD19+ B cell count and a remodeling of B cell subsets. The gene discussed is CD19; the disease is Alzheimer disease.